A new trading day began on Tuesday, with Vir Biotechnology Inc (NASDAQ: VIR) stock price up 2.05% from the previous day of trading, before settling in for the closing price of $7.82. VIR’s price has ranged from $7.41 to $13.09 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 421.39% over the last five years. Meanwhile, its annual earnings per share averaged 26.24%. With a float of $87.95 million, this company’s outstanding shares have now reached $134.78 million.
The firm has a total of 587 workers. Let’s measure their productivity. In terms of profitability, gross margin is 80.31%, operating margin of -673.27%, and the pretax margin is -682.39%.
Vir Biotechnology Inc (VIR) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Vir Biotechnology Inc is 35.64%, while institutional ownership is 51.03%. The most recent insider transaction that took place on Sep 09 ’24, was worth 95,032. In this transaction Director of this company sold 12,190 shares at a rate of $7.80, taking the stock ownership to the 11,616 shares. Before that another transaction happened on Sep 09 ’24, when Company’s Director proposed sale 12,190 for $7.76, making the entire transaction worth $94,594.
Vir Biotechnology Inc (VIR) Earnings and Forecasts
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -1.22 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.89 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 26.24% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.00% during the next five years compared to -34.12% drop over the previous five years of trading.
Vir Biotechnology Inc (NASDAQ: VIR) Trading Performance Indicators
Here are Vir Biotechnology Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 12.51. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.58, a number that is poised to hit -1.05 in the next quarter and is forecasted to reach -3.77 in one year’s time.
Technical Analysis of Vir Biotechnology Inc (VIR)
Analysing the last 5-days average volume posted by the [Vir Biotechnology Inc, VIR], we can find that recorded value of 0.75 million was lower than the volume posted last year of 1.03 million. As of the previous 9 days, the stock’s Stochastic %D was 32.79%. Additionally, its Average True Range was 0.38.
During the past 100 days, Vir Biotechnology Inc’s (VIR) raw stochastic average was set at 10.04%, which indicates a significant decrease from 36.54% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 42.86% in the past 14 days, which was lower than the 62.97% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.96, while its 200-day Moving Average is $9.64. Now, the first resistance to watch is $8.10. This is followed by the second major resistance level at $8.22. The third major resistance level sits at $8.37. If the price goes on to break the first support level at $7.83, it is likely to go to the next support level at $7.67. Should the price break the second support level, the third support level stands at $7.55.
Vir Biotechnology Inc (NASDAQ: VIR) Key Stats
With a market capitalization of 1.09 billion, the company has a total of 136,059K Shares Outstanding. Currently, annual sales are 86,180 K while annual income is -615,060 K. The company’s previous quarter sales were 3,080 K while its latest quarter income was -138,380 K.
